本页面由Tiger Trade Technology Pte. Ltd.提供服务

Astria Therapeutics Inc

12.87
-0.0500-0.39%
盘前13.000.1300+1.01%08:00 EST
成交量:130.28万
成交额:1,679.78万
市值:7.35亿
市盈率:-6.02
高:13.00
开:12.88
低:12.79
收:12.92
52周最高:13.29
52周最低:3.56
股本:5,708.48万
流通股本:3,838.30万
量比:1.09
换手率:3.39%
股息:- -
股息率:- -
每股收益(TTM):-2.1381
每股收益(LYR):-1.6784
净资产收益率:-43.15%
总资产收益率:-26.94%
市净率:2.53
市盈率(LYR):-7.67

数据加载中...

2025/12/03

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/11/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/11/12

重要事件披露

Form 8-K - Current report
2025/10/14

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/10/14

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/10/14

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/10/14

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/10/14

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/10/14

重要事件披露

Form 8-K - Current report
2025/10/14

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/08/12

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/08/12

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/08/06

重要事件披露

Form 8-K - Current report
2025/06/12

重要事件披露

Form 8-K - Current report
2025/05/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/03/11

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/11

重要事件披露

Form 8-K - Current report
2025/01/13

重要事件披露

Form 8-K - Current report
2024/12/19

重要事件披露

Form 8-K - Current report
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]